Yes, the love handle area is safe for tirzepatide injection when it falls within the FDA-approved abdominal zone, has adequate subcutaneous tissue, and maintains at least 2 inches distance from the navel
Avoid when: More specific documentation is available
Regular TSH and free T4 monitoring every 68 weeks is the gold standard for safe, effective management
According to the findings, losing 5.1 kg of weight was associated with a -4.44 mm Hg systolic and -3.57 mm Hg DBP drop
J Clin Immunol (2021) 41(3):51525
The FDA did not give the public a chance to weigh in on its decision and trusted assurances from Lilly, the company that is self-interested in monopolizing the market, that it could meet projected demand, the lawsuit said